Skip to main content
Premium Trial:

Request an Annual Quote

ParAllele and Merck to Collaborate on SNP Genotyping

Note: This article has been changed from an earlier version, in which the headline incorrectly referred to "SNP Discovery."

 

NEW YORK, July 9 - ParAllele BioScience of South San Francisco, today announced a SNP genotyping collaboration with Merck.

 

Financial details were not disclosed.

 

ParAllele will develop assays, perform multiplexed genotyping, and provide data analysis using its lab-in-a-tube technology, a multiplex system of single-tube assays for discovering and screening genetic markers

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.